ARTICLE SUMMARY:
At the Transcatheter Cardiovascular Therapeutics conference in Washington, DC, veteran medtech investors implored innovators to plan their reimbursement strategy as early as possible in their company’s development.
Adequate reimbursement from third-party payors remains a major impediment to medtech innovation according to panelists at the recent Transcatheter Cardiovascular Therapeutics MedTech Innovation Forum in Washington, DC, on October 27.
